You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

After non-radical hepatectomy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hepatic Carcinoma Trial in Wuhan (Huaier Granule)

Terminated
  • Hepatic Carcinoma
  • Huaier Granule
  • Wuhan, Hubei, China
    Tongji Hospital Affiliated to Tongji Medical College, Huazhong
Mar 5, 2020

Relapse After Conversion Hepatectomy for Initially Unresectable

Completed
  • Colorectal Cancer
  • Liver Metastases
  • Repeat Liver Surgery
  • Non-Repeat Liver Surgery
  • (no location specified)
Jul 16, 2022

Chemo Effect, Rectal Cancer Trial in Guangzhou (Radical total mesorectal excision, Salavge Adjuvant Chemoradiotherapy)

Recruiting
  • Chemotherapy Effect
  • Rectal Cancer
  • Radical total mesorectal excision
  • Salavge Adjuvant Chemoradiotherapy
  • Guangzhou, Guangdong, China
    Gastrointestinal Hospital, Sun Yat-sen University
Sep 12, 2023

Gastric Cancer Trial in Nanjing (Closure of the mesenteric defects, Non-closure of the mesenteric defects)

Not yet recruiting
  • Gastric Cancer
  • Closure of the mesenteric defects
  • Non-closure of the mesenteric defects
  • Nanjing, Jiangsu, China
    The First Affiliated Hospital of Nanjing Medical University
Apr 29, 2022

Pancreatic Carcinoma, Adjuvant Chemo, Cancer-related Fatigue Trial in Hangzhou (Codonopsis, Placebo)

Recruiting
  • Pancreatic Carcinoma
  • +2 more
  • Hangzhou, Other (Non U.s.), China
    Zhejiang Provincial People'S Hospital
Nov 10, 2022

NSCLC Trial in Guangzhou (Hypofractionated radiotherapy, induction chemo-immunotherapy, concurrent chemo)

Recruiting
  • Non-small Cell Lung Cancer
  • Hypofractionated radiotherapy
  • +4 more
  • Guangzhou, Guangdong, China
    Sun yat-sen university cancer center
Nov 14, 2023

MRD Monitoring in Lung Cancer After Resection

Recruiting
  • Lung Cancer
  • MRD detection
  • Guangzhou, Guangdong, China
    Guangdong Lung Cancer Institute & Guangdong Provincial People's
Mar 2, 2022

Using Non-invasive Multi-Technology Measurements for Early

Terminated
  • Occult Bleeding
  • +2 more
    • Columbus, Ohio
      The Ohio State University Comprehensive Cancer Center
    Dec 15, 2021

    Analgesia Trial in Mansoura (ultrasound approach of serratus anterior block, open approach of serratus anterior block)

    Recruiting
    • Analgesia
    • ultrasound approach of serratus anterior block
    • open approach of serratus anterior block
    • Mansoura, Dakahlia, Egypt
      Department of Anesthesia, Mansoura University Hospitals
    Feb 14, 2022

    Robot-assisted vs Laparoscopic vs Open Radical Cholecystectomy

    Enrolling by invitation
    • Gallbladder Cancer
    • Minimally invasive surgery
    • Barcelona, Spain
      Hospital del Mar
    Sep 25, 2023

    Primary Liver Cancer, Metastatic Liver Cancer, Benign Liver Tumors Trial

    Not yet recruiting
    • Primary Liver Cancer
    • +3 more
      • (no location specified)
      Aug 1, 2023

      Liver Regeneration, Ursodeoxycholic Acid, Partial Liver Resection Trial in New Delhi (Ursodeoxycholic acid, Standard Medical

      Not yet recruiting
      • Liver Regeneration
      • +2 more
      • Ursodeoxycholic acid
      • Standard Medical Treatment
      • New Delhi, India
        Institute of Liver and Biliary Sciences
      Oct 18, 2023

      Hepatocellular Carcinoma Trial in Nanning (Entecavir, Tenofovir)

      Recruiting
      • Hepatocellular Carcinoma
      • Nanning, Guangxi, China
        Department of Hepatobilliary Surgery, Affiliated Tumor of Guangx
      Jan 14, 2022

      Combined HAIC, TKI/Anti-VEGF and ICIs as Conversion Therapy for

      Recruiting
      • Hepatocellular Carcinoma Non-resectable
      • HAIC
      • +8 more
      • Quanzhou, Fujian, China
      • +1 more
      Jan 26, 2023

      Combined TACE, TKI/Anti-VEGF and ICIs as Conversion Therapy for

      Recruiting
      • Hepatocellular Carcinoma Non-resectable
      • TACE
      • +8 more
      • Quanzhou, Fujian, China
      • +3 more
      Jan 29, 2023

      Predicting Complications of Hepatolithiasis After Hepatectomy

      Enrolling by invitation
      • Liver Diseases
      • Complication
      • radiological evaluation
      • Wenzhou, Zhejiang, China
        Gang Chen
      Sep 23, 2022

      Hepatocellular Carcinoma Trial in Beijing (Donafenib)

      Not yet recruiting
      • Hepatocellular Carcinoma
      • Beijing, China
        Chinese Academy of Medical Sciences & Peking Union Medical Colle
      Dec 2, 2021

      Hepatocellular Carcinoma Trial in Villejuif (RAPID procedure)

      Not yet recruiting
      • Hepatocellular Carcinoma
      • RAPID procedure
      • Villejuif, France
        AP-HP, Paul Brousse Hospital
      Jul 24, 2023

      Hepatic Hemangioma, Liver Cancer, Hepatolithiasis Trial in Chongqing (Sham-Remote Ischemic Conditioning, Remote Ischemic

      Recruiting
      • Hepatic Hemangioma
      • +3 more
      • Sham-Remote Ischemic Conditioning
      • +2 more
      • Chongqing, China
        The Second Affiliated Hospital, Chongqing Medical University
      Nov 8, 2023

      Stomach Tumor Trial in Bucheon-Si (Oozfix, Greenplast)

      Recruiting
      • Stomach Neoplasm
      • Bucheon-Si, Korea, Republic of
        BucheonStMarys
      Dec 8, 2022

      Liver Cancer, Sarcopenia Trial in Wenzhou (gait speed; ct scan;grip strength and chair stand test)

      Enrolling by invitation
      • Liver Cancer
      • Sarcopenia
      • gait speed; ct scan;grip strength and chair stand test
      • Wenzhou, Zhejiang, China
        Gang Chen
      Jun 14, 2022

      Esophageal Squamous Cell Carcinoma, Chemo Effect, Side Effect of Drug Trial in Nanjing (Consolidation chemo (4 courses),

      Recruiting
      • Esophageal Squamous Cell Carcinoma
      • +2 more
      • Consolidation chemotherapy (4 courses)
      • Concurrent chemotherapy (2 courses)
      • Nanjing, Jiangsu, China
        The First Affiliated Hospital of Nanjing Medical University
      Mar 16, 2023

      Urinary Bladder Cancer Trial in Assiut (cystectomy)

      Recruiting
      • Urinary Bladder Cancer
      • cystectomy
      • Assiut, أسيوط, Egypt
        Assiut university hospital
      Oct 29, 2023

      Hepatocellular Carcinoma, Recurrence Trial in Guangzhou (Sorafenib)

      Terminated
      • Hepatocellular Carcinoma
      • Recurrence
      • Guangzhou, Guangdong, China
        Sun Yat-sen University Cancer Center
      Feb 9, 2020

      Hepatic Carcinoma, Hepatic Metastasis Trial in Pamplona (Octreotide, Placebo)

      Recruiting
      • Hepatic Carcinoma
      • Hepatic Metastasis
      • Pamplona, Spain
        Clinica Universidad de Navarra
      Oct 10, 2023